Peroxisome proliferator-activated receptor-γ2 P12A and type 2 diabetes in Canadian Oji-Cree

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 5, 2000, Pages 2014-2019

  Hegele, Robert A ^a,d   Cao, Henian ^a   Harris, Stewart B ^b,e   Zinman, Bernard ^c   Hanley, Anthony J G ^c   Anderson, Carol M ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d HEART AND STROKE FOUNDATION OF CANADA   (Canada)

^e ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; ARTICLE; CANADA; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; ALLELES; AMINO ACID SUBSTITUTION; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMANS; INDIANS, NORTH AMERICAN; INSULIN; MALE; MIDDLE AGED; NUCLEAR PROTEINS; ONTARIO; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SEX CHARACTERISTICS; TRANSCRIPTION FACTORS; VARIATION (GENETICS);

EID: 0034458034     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.5.2014     Document Type: Article

References (24)

1. The hepatic nuclear factor-1α G319S variant is associated with early onset type 2 diabetes in Canadian Oji-Cree
2. HNF-1α G319S: A private mutation in Oji-Cree associated with type 2 diabetes
3. The nuclear receptor PPARγ - Bigger than fat
4. Thiazolidinediones, and insulin resistance: Peroxisome proliferator activated receptor γ activation stimulates expression of the CAP gene
5. PPAR-γ: Adipogenic regulator, and thiazolidinedione receptor
6. Chromosomal localization, and partial genomic structure of the human peroxisome proliferator activated receptor-γ (hPPAR-γ) gene
7. Molecular scanning of the human peroxisome proliferator activated receptor γ (PPARγ) gene in diabetic Caucasians: Identification of a Pro12Ala PPAR-γ2 missense mutation
8. Association of the pro12ala variant in the peroxisome proliferator-activated receptor-γ-2 gene with obesity in two Caucasian populations
9. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
10. Pro. 12Ala substitution in the peroxisome proliferator-activated receptor is not associated with type 2 diabetes
11. Genome-wide scanning for type 2 diabetes susceptibility in Canadian Oji-Cree, using 190 microsatellite markers
12. The prevalence of NIDDM, and associated risk factors in native Canadians
13. Specific patterns of food consumption, and preparation are associated with diabetes and obesity in a native Canadian community
14. Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians
15. Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus
16. Paraoxonase-2 G148 variant in an aboriginal Canadian girl with non-insulin-dependent diabetes
17. Absence of association between genetic variation of the β 3-adrenergic receptor and metabolic phenotypes in Oji-Cree
18. Methylenetetra-hydrofolate reductase gene, dietary folate, NIDDM, and atherosclerosis in Canadian Oji-Cree
19. Hemochromatosis and diabetes mellitus
20. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
21. The organization, promoter analysis, and expression of the human PPARγ gene
22. Serum immunoreactive leptin concentrations in a Canadian aboriginal population with high rates of NIDDM